ATE407664T1 - Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben. - Google Patents
Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.Info
- Publication number
- ATE407664T1 ATE407664T1 AT00904513T AT00904513T ATE407664T1 AT E407664 T1 ATE407664 T1 AT E407664T1 AT 00904513 T AT00904513 T AT 00904513T AT 00904513 T AT00904513 T AT 00904513T AT E407664 T1 ATE407664 T1 AT E407664T1
- Authority
- AT
- Austria
- Prior art keywords
- macromolecles
- production
- same
- delayed release
- compositions suitable
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polymerisation Methods In General (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11754699P | 1999-01-28 | 1999-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE407664T1 true ATE407664T1 (de) | 2008-09-15 |
Family
ID=22373509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00904513T ATE407664T1 (de) | 1999-01-28 | 2000-01-26 | Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6361797B1 (de) |
| EP (1) | EP1067911B1 (de) |
| JP (1) | JP2002535452A (de) |
| AT (1) | ATE407664T1 (de) |
| AU (1) | AU757605B2 (de) |
| CA (1) | CA2325386C (de) |
| DE (1) | DE60040190D1 (de) |
| DK (1) | DK1067911T3 (de) |
| ES (1) | ES2313879T3 (de) |
| PT (1) | PT1067911E (de) |
| WO (1) | WO2000044356A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6544555B2 (en) * | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| DE10049297A1 (de) | 2000-10-04 | 2002-04-11 | Basf Ag | Wasserlösliche oder wasserdispergierbare (Co-)Polymerisate von Hydroxyalkyl(meth)acrylaten, Verfahren zu deren Herstellung sowie deren Verwendung als Überzugs-, Bindemittel und/oder filmbildender Hilfsstoff in pharmazeutischen Darreichungsformen |
| US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| EP1482994A1 (de) * | 2002-03-11 | 2004-12-08 | First Water Limited | Saugfähige hydrogele |
| US20060127878A1 (en) * | 2002-12-18 | 2006-06-15 | Salomon David H | Hydrogel preparation and process of manufacture thereof |
| US20040214914A1 (en) * | 2003-04-24 | 2004-10-28 | Ocular Sciences, Inc. | Hydrogel contact lenses and package systems and production methods for same |
| WO2006009801A2 (en) | 2004-06-17 | 2006-01-26 | Valera Pharmaceuticals, Inc. | Compositions and methods for treating central precocious puberty |
| EP1804824B1 (de) | 2004-09-29 | 2017-01-04 | Icahn School of Medicine at Mount Sinai | Fsh- und fsh-rezeptor-modulatorverbindungen und verfahren zur verhinderung osteoklastischen knochenschwundes und knochenverlustes bei osteoporose |
| US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
| WO2006099288A2 (en) | 2005-03-11 | 2006-09-21 | Indevus Pharmaceuticals, Inc. | Controlled release formulations of octreotide |
| NZ543314A (en) * | 2005-10-28 | 2007-08-31 | Interag | A delivery system where the driving substance contains the active component |
| RU2463079C2 (ru) | 2007-04-27 | 2012-10-10 | Эндо Фармасьютикалз Солюшнз Инк. | Разделительные агенты для имплантируемого устройства и способы их применения |
| US8222015B2 (en) | 2007-05-11 | 2012-07-17 | Toyota Motor Engineering & Manufacturing North America, Inc. | Heat resistant bioactive composition |
| US8303536B2 (en) * | 2007-08-30 | 2012-11-06 | Sunstorm Research Corp. | Implantable delivery device |
| US8071537B2 (en) | 2008-06-25 | 2011-12-06 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the sustained release of a polypeptide |
| EP2317975B1 (de) * | 2008-06-25 | 2016-04-13 | Endo Pharmaceuticals Solutions Inc. | Octreotid-implantat mit freisetzungsmittel |
| AU2010314994B2 (en) | 2009-11-09 | 2016-10-06 | Spotlight Technology Partners Llc | Fragmented hydrogels |
| JP5864429B2 (ja) | 2009-11-09 | 2016-02-17 | スポットライト テクノロジー パートナーズ エルエルシーＳｐｏｔｌｉｇｈｔ Ｔｅｃｈｎｏｌｏｇｙ Ｐａｒｔｎｅｒｓ Ｌｌｃ | 架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット |
| US8329219B2 (en) | 2009-12-22 | 2012-12-11 | Cook Biotech Incorporated | Methods for producing ECM-based biomaterials |
| CN104822366B (zh) * | 2012-07-13 | 2018-03-06 | 塔夫茨大学 | 在丝纤蛋白生物材料中香料和/或调味剂的包封 |
| JP6387009B2 (ja) | 2012-10-20 | 2018-09-05 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 癌細胞トラップ |
| WO2015143295A2 (en) | 2014-03-20 | 2015-09-24 | The Regents Of The University Of California | Hydrogel compositions containing toxin-absorbing or binding nanoparticles and uses thereof |
| WO2019117976A1 (en) | 2017-12-17 | 2019-06-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Peptide hydrogels and use thereof |
| EP3791864A1 (de) | 2019-09-13 | 2021-03-17 | UPM-Kymmene Corporation | Verfahren zur herstellung einer pharmazeutischen zusammensetzung sowie pharmazeutische zusammensetzung |
| EP3791858A1 (de) * | 2019-09-13 | 2021-03-17 | UPM-Kymmene Corporation | Injizierbare pharmazeutische formulierung |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4298002A (en) * | 1979-09-10 | 1981-11-03 | National Patent Development Corporation | Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation |
| US4959217A (en) * | 1986-05-22 | 1990-09-25 | Syntex (U.S.A.) Inc. | Delayed/sustained release of macromolecules |
| AU618817B2 (en) * | 1988-07-05 | 1992-01-09 | Novartis Ag | Dimethylacrylamide-copolymer hydrogels with high oxygen permeability |
| US4954587A (en) * | 1988-07-05 | 1990-09-04 | Ciba-Geigy Corporation | Dimethylacrylamide-copolymer hydrogels with high oxygen permeability |
| AU651654B2 (en) * | 1992-01-14 | 1994-07-28 | Endo Pharmaceuticals Solutions Inc. | Manufacture of water-swellable hydrophilic articles and drug delivery devices |
| US5266325A (en) * | 1990-09-28 | 1993-11-30 | Hydro Med Science Division Of National Patent Development Corp. | Preparation of homogeneous hydrogel copolymers |
| ATE106015T1 (de) * | 1990-09-28 | 1994-06-15 | Pfizer | Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält. |
| JPH04202201A (ja) * | 1990-11-29 | 1992-07-23 | Mitsui Toatsu Chem Inc | 多孔性共重合体の製造方法 |
| JP2530079B2 (ja) * | 1992-02-05 | 1996-09-04 | ナショナル・パテント・ディベロプメント・コーポレーション | 水分膨潤性親水性製品及び薬物放出装置の製造 |
-
2000
- 2000-01-26 CA CA2325386A patent/CA2325386C/en not_active Expired - Fee Related
- 2000-01-26 AT AT00904513T patent/ATE407664T1/de not_active IP Right Cessation
- 2000-01-26 DK DK00904513T patent/DK1067911T3/da active
- 2000-01-26 US US09/646,066 patent/US6361797B1/en not_active Expired - Lifetime
- 2000-01-26 EP EP00904513A patent/EP1067911B1/de not_active Expired - Lifetime
- 2000-01-26 ES ES00904513T patent/ES2313879T3/es not_active Expired - Lifetime
- 2000-01-26 WO PCT/US2000/001664 patent/WO2000044356A1/en not_active Ceased
- 2000-01-26 AU AU26256/00A patent/AU757605B2/en not_active Ceased
- 2000-01-26 JP JP2000595660A patent/JP2002535452A/ja active Pending
- 2000-01-26 DE DE60040190T patent/DE60040190D1/de not_active Expired - Lifetime
- 2000-01-26 PT PT00904513T patent/PT1067911E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60040190D1 (de) | 2008-10-23 |
| AU757605B2 (en) | 2003-02-27 |
| PT1067911E (pt) | 2008-12-22 |
| DK1067911T3 (da) | 2009-01-26 |
| EP1067911A1 (de) | 2001-01-17 |
| AU2625600A (en) | 2000-08-18 |
| US6361797B1 (en) | 2002-03-26 |
| EP1067911A4 (de) | 2003-05-21 |
| EP1067911B1 (de) | 2008-09-10 |
| CA2325386C (en) | 2010-03-23 |
| WO2000044356A1 (en) | 2000-08-03 |
| JP2002535452A (ja) | 2002-10-22 |
| ES2313879T3 (es) | 2009-03-16 |
| CA2325386A1 (en) | 2000-08-03 |
| WO2000044356A9 (en) | 2001-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60040190D1 (de) | Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben. | |
| DE602004030821D1 (de) | Poröse verbundmaterialien sowie verfahren zur herstellung und verwendung davon | |
| DE60011243D1 (de) | Verfahren zur herstellung von mit antioxidant gedoptem uhmwpe und daraus hergestelltes implantat | |
| DE60323340D1 (de) | Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle | |
| ATE487746T1 (de) | Geträgerter hybridmetallocenkatalysator, herstellungsverfahren dafür und verfahren zur herstellung von polyolefinen damit | |
| ATE292959T1 (de) | Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität | |
| ATE389678T1 (de) | Verfahren zur herstellung von wässrigen dispersionen | |
| ATE464373T1 (de) | Zelluläre zusammensetzungen und verfahren zur deren bereitung und verwendung | |
| ATE296094T1 (de) | Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen | |
| ATE224927T1 (de) | Filamentöse, poröse filme und verfahren zu ihrer herstellung | |
| ATE430160T1 (de) | Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte | |
| ATE372336T1 (de) | Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen | |
| DE60014123D1 (de) | Verfahren zur herstellung von porösen polymerpellets | |
| ATE461226T1 (de) | Verfahren zur herstellung von polyacrolein | |
| ATE537173T1 (de) | Verfahren zur herstellung von cucurbiturilen | |
| DE50105968D1 (de) | VERFAHREN ZUR HERSTELLUNG VON AlKYLVERBRÜCKTEN LIGANDSYSTEMEN UND ÜBERGANGSMETALLVERBINDUNGEN | |
| ATE369122T1 (de) | Verfahren zur herstellung von implantaten mittels lösungsmittelfreier herstellung eines homogenisats | |
| DE59909917D1 (de) | Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel | |
| ATE476426T1 (de) | Verfahren zur herstellung von alkoxycarbonylamino-triazinen | |
| DE602005009978D1 (de) | Verfahren zur herstellung von zwei- und dreidimensionalen polymergerüsten | |
| DE602004003037D1 (de) | Verfahren und zwischenprodukte für die herstellung von emtricitabin | |
| DE502004010100D1 (de) | Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben | |
| DE60006111D1 (de) | Aluminosiloxanverbindungen und verfahren zu ihrer herstellung | |
| ATE440605T1 (de) | Verfahren zur herstellung von camptothecin- derivaten | |
| ATE374755T1 (de) | Verfahren zur herstellung von 1,3,5- triazincarbamaten und -harnstoffen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1067911 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |